OR WAIT null SECS
ChromaDex Corp. has launched Tru Niagen Pro 500, the largest daily serving of its patented nicotinamide riboside.
ChromaDex Corp. (Los Angeles, CA) has launched Tru Niagen Pro 500, the largest daily serving of its patented nicotinamide riboside (NR). The product will be exclusively available through licensed healthcare practitioners in the United States.
“This new product will allow practitioners to provide a unique product to their patients who want more energy and improved cellular health,” said ChromaDex CEO Rob Fried, in a press release.
“We are pleased to launch this new product exclusively through the healthcare practitioner channel,” added ChromaDex chief scientific officer Matthew Roberts, PhD. “This new product launch marks a major milestone in a year already characterized by several new significant scientific publications, human clinical data, and regulatory approvals around the world for ChromaDex.”